Isolation of the Spermatic Cord in Mesh Inguinal Hernia Repair

NCT ID: NCT01391455

Last Updated: 2011-07-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

220 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-07-31

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There are in excess of 1 million operations performed annually to repair inguinal hernias, mostly in the male population. Unfortunately, some patients continue to suffer both groin or testicular pain for varying lengths of time postoperatively. This can lead to a severe degradation of the patient's lifestyle, work habits and sexual function. The origin of the pain is felt to be secondary to the inflammatory reaction caused by the mesh. This also involves the spermatic cord and its structures, leading to orchidinia and possibly azospermia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this prospective randomized trial, male patients with a primary symptomatic unilateral inguinal hernia will be admitted to the trial. All patients must be over 21 years of age. In order to avoid inguinal nerve entrapment or damage by mesh fixation sutures Covidien Parietene ProGrip mesh will be employed. This mesh does not require fixation. Standard open inguinal hernia repair will take place with nerve preservation, as day surgery cases. In the randomized portion of the study, the mesh will be placed as usual along the posterior wall of the inguinal canal, however the inguinal ligament will be interposed between the mesh and the spermatic cord, thus isolating the cord from intimate contact with the mesh, and a reduction in postoperative inflammatory changes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inguinal Hernia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Spermatic Cord in contact with mesh

Where the spermatic cord has been allowed to remain in contact with the mesh.

Group Type NO_INTERVENTION

No interventions assigned to this group

Spermatic Cord is isolated from the mesh

The inguinal ligament is interposed between the cord and the mesh and then repaired. This isolates the cord from the mesh and the splinting function of the overlying inguinal ligament.

Group Type EXPERIMENTAL

Isolation of the spermatic cord from mesh

Intervention Type PROCEDURE

The spermatic cord is isolated from the mesh employed to repair an inguinal hernia following standard open repair.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Isolation of the spermatic cord from mesh

The spermatic cord is isolated from the mesh employed to repair an inguinal hernia following standard open repair.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of a primary unilateral inguinal hernia

Exclusion Criteria

* Medically unfit for surgical repair
Minimum Eligible Age

21 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chatham Kent Health Alliance

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Chatham Kent Health Alliance

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

John A Morrison, MD;FRCS(C)

Role: PRINCIPAL_INVESTIGATOR

Chatham Kent Health Alliance

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chatham Kent Health Alliance

Chatham, Ontario, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

John A Morrison, MD; FRCS(C)

Role: CONTACT

519 352 0503

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

John A Morrison, MD;FRCS(C)

Role: primary

519 352 0503

Gary Tithecott, MD;FRCP(C)

Role: backup

519 3526400

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

mesh isolation

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Emergency Hernia Repair
NCT07314398 NOT_YET_RECRUITING